Deep Track Capital’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5M Buy
+2,643,542
New +$22.7M 0.35% 51
2024
Q4
Sell
-1,963,505
Closed -$38.4M 72
2024
Q3
$38.4M Buy
1,963,505
+1,578,749
+410% +$32M 1.22% 29
2024
Q2
$7.92M Buy
+384,756
New +$7.91M 0.24% 53
2022
Q4
Sell
-3,186,083
Closed -$43.5M 68
2022
Q3
$43.5M Sell
3,186,083
-511,886
-14% -$7.9M 1.99% 15
2022
Q2
$67.8M Buy
3,697,969
+285,969
+8% +$4.11M 4.46% 6
2022
Q1
$54.9M Buy
3,412,000
+862,000
+34% +$12.4M 3.52% 11
2021
Q4
$35.7M Buy
+2,550,000
New +$41.3M 2.52% 15

Other funds holding KURA

Deep Track Capital's KURA Position: Q1 2026 in Review

Deep Track Capital opened a new position in Kura Oncology (KURA) in Q1 2026: 2,643,542 shares worth $21.5M. The stake represents 0.35% of the portfolio and ranks #51 among its holdings. This is a return to the name: Deep Track Capital previously reported a position in KURA as recently as Q3 2024.

Deep Track Capital first reported a position in KURA in Q4 2021 and has held it in 7 quarters since. The position peaked at $67.8M in Q2 2022. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Deep Track Capital held 2,643,542 shares of Kura Oncology worth $21.5M as of Q1 2026.
  • Kura Oncology was a new Deep Track Capital position in Q1 2026.
  • Kura Oncology made up 0.35% of Deep Track Capital's portfolio in Q1 2026, its #51 holding.
  • Deep Track Capital first reported a position in Kura Oncology in Q4 2021 and has held it in 7 quarters since.
  • Deep Track Capital's Kura Oncology position peaked at $67.8M in Q2 2022.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Deep Track Capital's 13F filing for Q1 2026, filed 15 May 2026.